Resistance to progressive growth of tumours induced by Rous sarcoma virus is controlled mainly by genes linked to the B complex (the major histocompatibility complex) of the chicken. The effect of thymectomy and bursectomy on this resistance was studied in chickens from highly inbred lines and their F1 hybrids which differ by the genotype at the B complex and by the degree of genetically controlled resistance or susceptibility. The results show that thymectomy has considerable effect on growth of RSV-induced tumours in the CB line genetically resistant to progressive Rous sarcoma growth and little effect in (CB X IC)F1 (also genetically resistant) and (CC X IC)F1 (intermediate responders to RSV) hybrid chickens. Bursectomy influences the expression of this resistance to a lesser extent than thymectomy. The results indicate that resistance to the development of progressively growing tumours is of a complex nature, the individual components of the immune system are more or less important for its expression in different experimental models. Thus genetically defined animal models have become useful tools for studying carcinogenesis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

rous sarcoma
12
inbred lines
8
genetically resistant
8
resistance
5
primary lymphoid
4
lymphoid organs
4
organs rous
4
sarcoma regression
4
regression inbred
4
lines chickens
4

Similar Publications

Zoonotic viruses are an omnipresent threat to global health. Influenza A virus (IAV) transmits between birds, livestock, and humans. Proviral host factors involved in the cross-species interface are well known.

View Article and Find Full Text PDF

Serine 31 is a phospho-site unique to the histone H3.3 variant; mitotic phospho-Ser31 is restricted to pericentromeric heterochromatin, and disruption of phospho-Ser31 results in chromosome segregation defects and loss of p53-dependant G cell-cycle arrest. Ser31 is proximal to the H3.

View Article and Find Full Text PDF

A Novel Rat Model to Simulate Positive Margins in the Wound Bed of a Resected Sarcoma.

Plast Reconstr Surg Glob Open

November 2024

From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Stony Brook University Hospital and Medical Center, Stony Brook, NY.

Background: One reason for local recurrence is the presence of positive surgical margins after tumor resection. An animal model accurately representing the microtumor burden will improve our understanding of these surgical margins. Using a rat model, we report a new methodology for creating microscopic tumors.

View Article and Find Full Text PDF

Avian Models for Human Carcinogenesis-Recent Findings from Molecular and Clinical Research.

Cells

October 2024

Division of Anatomy, Department of Human Morphology and Embryology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw, Poland.

Birds, especially the chick and hen, have been important biomedical research models for centuries due to the accessibility of the avian embryo and the early discovery of avian viruses. Comprehension of avian tumor virology was a milestone in basic cancer research, as was that of non-viral genesis, as it enabled the discovery of oncogenes. Furthermore, studies on avian viruses provided initial insights into Kaposi's sarcoma and EBV-induced diseases.

View Article and Find Full Text PDF
Article Synopsis
  • - KRAS mutations lead to aggressive tumors and drug resistance in colorectal cancer, making treatment difficult, particularly with targeted therapies like regorafenib.
  • - TRIM21, influenced by ERK2 and KRAS signaling, plays a key role in regulating c-Myc, which affects glycolysis and contributes to resistance to regorafenib.
  • - Targeting TRIM21 to inhibit its phosphorylation may improve treatments for KRAS-mutant colorectal cancer, with the antidepressant vilazodone showing promise in enhancing the effectiveness of regorafenib in research models.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!